{"name":"Vigonvita Life Sciences","slug":"vigonvita-life-sciences","ticker":"","exchange":"","domain":"vigonvitalifesciences.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TPN171H","genericName":"TPN171H","slug":"tpn171h","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"TPN171H","genericName":"TPN171H","slug":"tpn171h","phase":"phase_3","mechanism":"TPN171H is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes","Heart failure"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQdk9YNFN5WWtmRUJvMktLOUhMV213MDdjRzJvVEFtYjlTS21OOS10UExRcm9BYkZ5aUNoMFZfd3ZldFNoT1NqSW5ZbnBKdjB5NzV5Q011Rjh6Q1ZucVlLYlBuQXR0NDdGSTBBNzczY1liamZaV0xLVjRVTzgwTHZSWk5CR2E1MHRfTGtGa19CTWVMbTlVTkw3aWJ2cl9zdk5EYmVXMlZrdi11endYMUt1RW5RdnZMR2JQNG5OTjR4YVNkZF9qRnJ1WXZ0YWY3NW1UajVXc0ota01MY1NGTXdGTElBeWd1b01tTHlfa0hxNEh3WmhESFFOTXk0bTQ2UQ?oc=5","date":"2026-02-05","type":"pipeline","source":"Barchart.com","summary":"Pulmonary Arterial Hypertension Pipeline Outlook: 55+ Companies Advancing Next-Generation Treatment Options, analyses DelveInsight - Barchart.com","headline":"Pulmonary Arterial Hypertension Pipeline Outlook: 55+ Companies Advancing Next-Generation Treatment Options, analyses De","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQMmVQSXhzeHhEN3ZoQ1hUaDRjcEt1aGlTcmNGSjlqbVlGLVE0OWZYdlk3X1RnNjAzTndMYVhteENZSTJWdWN3R014Sk11a3lvZzlLN3V0Znh0T2hrMW1nb09jcS1ROUZBZzExVm5oclBMZi1ZV3VTMDdtendjaWFTcmplcXYxXy1CUDRvR2p4ajB1LWJ1OFdUemtkdVNmd1NNdmk5YVNvYjlPdGE4UHc?oc=5","date":"2026-01-27","type":"pipeline","source":"Laodong.vn","summary":"Nipah virus weakens before Chinese COVID-19 treatment drug - Laodong.vn","headline":"Nipah virus weakens before Chinese COVID-19 treatment drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxORmJ3UklCSFpaOGtzSTBCc1dIWk9pTHFoWTNpTmluOGpPODdaUXRCVDB6T21zVjRJa2p3TFlGZXJTbllFNkUxdUhQcGZ6aWE1V1IwRDVxVTRNTk1aUjRRTDVlaW9aWFVvSWp4SVNwcTNVY1RTalQ2aU1DbkNGRnVJZXl2YmJUSTFFcko1X0JKV19VY0Y1SVlnX2x1WG53eXVudWxWWF9CdWJ3Y1lHZjRWYjhtT1pTQQ?oc=5","date":"2025-11-24","type":"pipeline","source":"Deloitte","summary":"Deloitte China assists listing of Chuangxin Industries on SEHK - Deloitte","headline":"Deloitte China assists listing of Chuangxin Industries on SEHK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPRUF3MUJZS2lMZEVSZjdObHlyUU1uMjQ2ODJ2bmhxTEpudEFicURLYk1VTWxxZUtvYXFJOF9zYVVVRkR2VUpZa2kwZWtBYUdmc3ZWZDhBSzhORE5VcmNKQ0xGeGxpMjZOay1GX1NTRFhzTi1XOFFVZTdGbEg3dlhvaGQxV3NmOWZUNmhGLUpn?oc=5","date":"2025-11-07","type":"pipeline","source":"NAI500","summary":"Robotaxi debuts fade in HK amid IPO glut, US overhang - NAI500","headline":"Robotaxi debuts fade in HK amid IPO glut, US overhang - NAI500","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNWWRBVnVoZ3ljRGJvdUhMblJmNUhPcDBaWDZ2d0stVDZ4YXdIWFgzR2NqUVRnMXY3MGU3TVplRGNnOTczRVJLLUpOa0ZpQjZDbkE5aWdsOVkxMWdta09fNGh1a0tJZXFMT3RGaWh0WWFQU2hpQUZiOHoxM2F5emRmRTd5R0FOSnQ2cWJESFRFaXJMQ2FFM05MRW1BV2FiUlhBaF9FS1pmSjZSWlFsaWhHOTZsVmJPV2VwNjhWNXVaWTVZMGhJRjd0MTJTcw?oc=5","date":"2025-11-06","type":"pipeline","source":"Deloitte","summary":"Deloitte China assists listings of Pony AI and Vigonvita Life Sciences on SEHK - Deloitte","headline":"Deloitte China assists listings of Pony AI and Vigonvita Life Sciences on SEHK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-07-19","type":"pipeline","source":"prnewswire.com","summary":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer B","headline":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Ba","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxONFlXM1BhTmJIcXk5QVo2Tm52ZUMwVzRrZXdkNlhMc3NodkhPcS1FY3hScF93YUNyR2pLN0x6eFpGeWlZZWJZZWZTanVoLWlIdXYzNVN6bVZjYzdtcFdIb3ZWNkpxUjZJX2xjdTNBYWFLS0VUTzZ6UzVqZktTcU5jbWRveUxRV21BUl9KVUw3QmlfVVBjcU9Db2tjYU1SOG9DLWdUa1FVRlp6d9IBrAFBVV95cUxOb2tZNEdWTlFpYUxVWkJzRmJ3X1cwc094YXkzZXdWNGZ0VkItWGJGLTBqaUwxWFNBc0RBMUFtcGZhSTFUem13ZkxXYlVONVJFUkhQVV8wUFByYzQ3bXNKbjNtZXlXTXBnX21kLTJobWpRYTRZZWFwdTh1V1hsQ1NDZ242SzlEV3R1VlVtVV9RTmhRMkdqdjd6enZhOTlPU3VvWklYZlRZRHJQalQx?oc=5","date":"2023-01-09","type":"trial","source":"VOA - Voice of America English News","summary":"China Touts New Drug for Alleviating COVID-19 Now Undergoing Trials - VOA - Voice of America English News","headline":"China Touts New Drug for Alleviating COVID-19 Now Undergoing Trials - VOA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNTlhkWG9rSk5KemNhNlVFUm1hckZTTVVZX21wdWFHOG94STBqTWhZeEZzZ1VkX0I3YVhjSVVrc0pxMEtiM2RkX19YZF9nREp2ZjlxalF3cHRWam9aVmJEU1U5a19ReWNNM204T3NDWFp6VXN6ZDNNUUdHd2ZxY2V6dmVUWEk5dWgwYjF0alc0TGtiSWFnZ0NJ?oc=5","date":"2023-01-09","type":"pipeline","source":"Royal Australian College of General Practitioners (RACGP)","summary":"newsGP - New antiviral may offer ‘less cumbersome’ COVID treatment option - Royal Australian College of General Practitioners (RACGP)","headline":"newsGP - New antiviral may offer ‘less cumbersome’ COVID treatment option - Royal Australian College of General Practiti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxORGpyTlR3MUE2emNGOUlTSlVodVlWWFR4RVQ2ZnVZblVPVXduWVQ3ckdzamZVdWVhTjB2cm16U2w3WHdfZmJLUVJaNzd0NW4tM3FoWXNNZkdsNFRMNW9QQ0ViYlAxOEt6dDdlLUtrd0lXb2dyMzMyb19NQmZ3MnZ1VFNmWTBwenNHMENDNkprbU15VFRLRjdhSGZmYlk3X0lNRm16OGNn?oc=5","date":"2022-12-29","type":"trial","source":"NBC News","summary":"A promising new Covid pill shows key advantages over Paxlovid in trial - NBC News","headline":"A promising new Covid pill shows key advantages over Paxlovid in trial","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}